Skip to main content
Clinical Trials/ISRCTN11211024
ISRCTN11211024
Completed
未知

Carer administration of as-needed subcutaneous medication for breakthrough symptoms in home-based dying patients: a UK study (CARIAD)

Bangor University0 sites40 target enrollmentSeptember 27, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Bangor University
Enrollment
40
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

2019 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/30732624 protocol 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32484432/ (added 28/10/2022)

Registry
who.int
Start Date
September 27, 2016
End Date
September 30, 2019
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Dyads of dying patients and their home\-based carers
  • 2\. Adult patients in the last weeks of life
  • 3\. Who are likely to use the oral route for medication
  • 4\. Have expressed a preference to die at home
  • 5\. Have a family carer who is over 18
  • 6\. Carer is willing to have this extended role
  • 7\. Carer is willing to have subcutaneous injection training

Exclusion Criteria

  • 1\. Patient or carer is under 18
  • 2\. Patient or carer not willing to entertain concept of lay carer administering subcutaneous medication
  • 3\. Patient or carer has a known history of substance abuse
  • 4\. Patient has had previous known adverse reactions to substance meds
  • 5\. Clinician judges that risk assessment criteria are not met for a dyad

Outcomes

Primary Outcomes

Not specified

Similar Trials